Colquhoun, A J <br/><br/>
Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo.  [electronic resource] 

 -  Journal of radiation research  Sep 2007 
 - 351-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0449-3060 
<br/><br/><label>Standard No.: </label>10.1269/jrr.07014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Cell Proliferation--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Gefitinib<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Quinazolines--administration & dosage<br/>Radiotherapy, Adjuvant--methods<br/>Treatment Outcome<br/>Tumor Cells, Cultured<br/>Urinary Bladder Neoplasms--drug therapy